Karyopharm Therapeutics Inc. (KPTIQ) stock
KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Karyopharm Therapeutics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Karyopharm Therapeutics's ebitda for the twelve months ending Sep 30, 2020 was -$177.09M. For fiscal 2019 it was -$188.30M. The highest annual figure on record is -$10.23M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | -$188.30M | – |
| FY2018 | Dec 31, 2018 | -$179.15M | – |
| FY2017 | Dec 31, 2017 | -$129.83M | – |
| FY2016 | Dec 31, 2016 | -$110.02M | – |
| FY2015 | Dec 31, 2015 | -$118.44M | – |
| FY2014 | Dec 31, 2014 | -$75.52M | – |
| FY2013 | Dec 31, 2013 | -$33.81M | – |
| FY2012 | Dec 31, 2012 | -$15.77M | – |
| FY2011 | Dec 31, 2011 | -$10.23M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -$46.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$40.08M | – |
| Q1 FY2020 | Mar 31, 2020 | -$47.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$43.02M | – |
| Q3 FY2019 | Sep 30, 2019 | -$39.16M | – |
| Q2 FY2019 | Jun 30, 2019 | -$41.44M | – |
| Q1 FY2019 | Mar 31, 2019 | -$64.68M | – |
| Q4 FY2018 | Dec 31, 2018 | -$57.26M | – |
| Q3 FY2018 | Sep 30, 2018 | -$48.97M | – |
| Q2 FY2018 | Jun 30, 2018 | -$34.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$38.77M | – |
| Q4 FY2017 | Dec 31, 2017 | -$39.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$30.88M | – |
| Q2 FY2017 | Jun 30, 2017 | -$29.57M | – |
| Q1 FY2017 | Mar 31, 2017 | -$30.10M | – |
| Q4 FY2016 | Dec 31, 2016 | -$26.99M | – |
| Q3 FY2016 | Sep 30, 2016 | -$25.56M | – |
See a number that looks wrong?